Concepedia

Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease

Michael A. Bernstein, Sue P. Irwin, Gordon R. Greenberg

The American Journal of Gastroenterology · 2005 · 102 citations · 29 references

DOI

Abstract

Maintenance treatment with infliximab improves BMD in patients with CD and this effect is independent of corticosteroid administration. The BMD response after infliximab suggests that TNF-alpha plays a role in the bone loss associated with CD.

References

29

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.1K citations

, , +5

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.1K citations · Full text

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands, Frank Anderson, Çharles N. Bernstein et al. · New England Journal of Medicine · 2004 · 2.2K citations · Full text

The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

William A. Faubion, Edward V. Loftus, William S. Harmsen et al. · Gastroenterology · 2001 · 1.1K citations · Full text

, , +7